Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 27Ovarian Neoplasms 14Lung Neoplasms 12Melanoma 11Colorectal Neoplasms 9Breast Neoplasms 9Stomach Neoplasms 7Pancreatic Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 6Neoplasm Metastasis 6Mesothelioma 6Carcinoma, Merkel Cell 5Small Cell Lung Carcinoma 4Multiple Myeloma 4Mesothelioma, Malignant 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Urogenital Neoplasms 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Liver Neoplasms 3Cholangiocarcinoma 3Carcinoma, Squamous Cell 3Thymoma 2

Interventions

fludarabine 2aldesleukin 2Cyclophosphamide 2fludarabine phosphate 1figitumumab 1Paclitaxel 1Nivolumab 1Interleukin-2 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Adenosquamous × fludarabine × Thoracic × Clear all
NCT02133196 2026-06-05

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
85 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

NCT03215810 2023-07-24

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
20 enrolled 10 charts
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡